Nearly 1 in 6 Eye Clinic Patients Report Recent Marijuana Use—A Gap That Could Skew Glaucoma Diagnoses
The cannabis use glaucoma survey found that nearly 1 in 6 eye clinic patients reported recent marijuana use. This use may confound intraocular pressure measurements critical for glaucoma diagnosis. Understanding cannabis use patterns is essential for…
Artelo Biosciences Expands into Glaucoma Market with New Study – Intellectia AI
Artelo Biosciences glaucoma study highlights cannabinoids' potential for intraocular pressure reduction and neuroprotection. This clinical research advances understanding of cannabinoid therapeutic targets in glaucoma. Ongoing studies aim to optimize…
Artelo Biosciences Advances Peripheral Cannabinoid Agonists for Glaucoma
Peripheral cannabinoid receptor agonists glaucoma research is advancing with promising synthetic compounds like ART12.11. These therapies aim to reduce intraocular pressure, a key factor in glaucoma management. Clinicians should monitor emerging data on…
